A retrospective study of the CHOP, CHOPE, and CHOPE/G regimens as the first-line treatment of peripheral T-cell lymphomas

被引：0
|
作者：
Xuyan Liu
Mingzi Yang
Meng Wu
Wen Zheng
Yan Xie
Jun Zhu
Yuqin Song
Weiping Liu
机构：
[1] Peking University Cancer Hospital and Institute,Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma
来源：
Cancer Chemotherapy and Pharmacology | 2019年 / 83卷
关键词：
Peripheral T-cell lymphomas; Chemotherapy; CHOP; Etoposide; Gemcitabine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：443 / 449
页数：6
相关论文
共 50 条
  • [21] Real Life Experience of Brentuximab Vedotin Plus CHP As First-Line Treatment in CD30+Peripheral T-Cell Lymphomas
    Domenech Eva, Domingo
    Sancho, Juan-Manuel
    Gonzalez-Barca, Eva
    Kelleher, Nicholas
    Rodriguez-Luaces, Marta
    Rovira Sole, Jordina
    Verdesoto, Silvia
    Encuentra, Maite
    Blazevic, Damir
    Oliveira, Ana C.
    Escoda, Lourdes
    Ribera, Josep-Maria
    Sureda, Anna
    BLOOD, 2021, 138
  • [22] Alemtuzumab plus CHOP as front-line chemotherapy for patients with peripheral T-cell lymphomas: a phase II study
    Jong Gwang Kim
    Sang Kyun Sohn
    Yee Soo Chae
    Yoon Young Cho
    Deok Hwan Yang
    Je-Jung Lee
    Hyeoung-Joon Kim
    Ho Jin Shin
    Joo Seop Chung
    Goon Jae Cho
    Won-Sik Lee
    Young-Don Joo
    Chang-Hak Sohn
    Suk Joong Oh
    Cancer Chemotherapy and Pharmacology, 2007, 60 : 129 - 134
  • [23] Alemtuzumab plus CHOP as front-line chemotherapy for patients with peripheral T-cell lymphomas: a phase II study
    Kim, Jong Gwang
    Sohn, Sang Kyun
    Chae, Yee Soo
    Cho, Yoon Young
    Yang, Deok Hwan
    Lee, Je-Jung
    Kim, Hyeoung-Joon
    Shin, Ho Jin
    Chung, Joo Seop
    Cho, Goon Jae
    Lee, Won-Sik
    Joo, Young-Don
    Sohn, Chang-Hak
    Oh, Suk Joong
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (01) : 129 - 134
  • [24] FDA Approval Summary: Brentuximab Vedotin in First-Line Treatment of Peripheral T-Cell Lymphoma
    Richardson, Nicholas C.
    Kasamon, Yvette L.
    Chen, Haiyan
    de Claro, R. Angelo
    Ye, Jingjing
    Blumenthal, Gideon M.
    Farrell, Ann T.
    Pazdur, Richard
    ONCOLOGIST, 2019, 24 (05): : E180 - E187
  • [25] Treatment strategies for peripheral T-cell lymphomas
    Foss, Francine M.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2013, 26 (01) : 43 - 56
  • [26] BELINOSTAT FOR THE TREATMENT OF PERIPHERAL T-CELL LYMPHOMAS
    McDermott, J.
    Jimeno, A.
    DRUGS OF TODAY, 2014, 50 (05) : 337 - 345
  • [27] Gemcitabine, Ifosfamide, Oxaliplatin (GIFOX) as First-Line Treatment In High-Risk Peripheral T-Cell/NK Lymphomas: A Phase II Trial
    Corazzelli, Gaetano
    Frigeri, Ferdinando
    Marcacci, Gianpaolo
    Becchimanzi, Cristina
    Capobianco, Gaetana
    Arcamone, Manuela
    Morelli, Emanuela
    Volzone, Francesco
    Russo, Filippo
    Pinto, Antonio
    BLOOD, 2010, 116 (21) : 1167 - 1167
  • [28] Peripheral T-cell lymphoma: autologous hematopoietic cell transplantation as first-line therapy
    Laport, Ginna G.
    CURRENT OPINION IN ONCOLOGY, 2010, 22 (05) : 409 - 413
  • [29] The role of front-line anthracycline-containing chemotherapy regimens in peripheral T-cell lymphomas
    Briski, R.
    Feldman, A. L.
    Bailey, N. G.
    Lim, M. S.
    Ristow, K.
    Habermann, T. M.
    Macon, W. R.
    Inwards, D. J.
    Colgan, J. P.
    Nowakowski, G. S.
    Kaminski, M. S.
    Witzig, T. E.
    Ansell, S. M.
    Wilcox, R. A.
    BLOOD CANCER JOURNAL, 2014, 4 : e214 - e214
  • [30] The role of front-line anthracycline-containing chemotherapy regimens in peripheral T-cell lymphomas
    R Briski
    A L Feldman
    N G Bailey
    M S Lim
    K Ristow
    T M Habermann
    W R Macon
    D J Inwards
    J P Colgan
    G S Nowakowski
    M S Kaminski
    T E Witzig
    S M Ansell
    R A Wilcox
    Blood Cancer Journal, 2014, 4 : e214 - e214
12345